Varied Sleep Patterns for Cardiometabolic Health
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test how different sleep patterns affect energy and heart health. Participants will either follow a routine with varying sleep lengths across the week, known as Intermittent Short Sleep (ISS) and Social Jetlag (SJL), or maintain a steady sleep schedule, referred to as Sustained Adequate Sleep (SAS). The study will examine how these sleep patterns impact weight and heart-related risks. Ideal candidates are young to middle-aged adults who usually sleep 7-9 hours a night without sleep aids or naps. As an unphased trial, this study offers participants the opportunity to contribute to groundbreaking research on sleep and health.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking beta-blockers, anti-coagulants, or anti-platelets.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that insufficient sleep links to higher risks of health problems like heart disease and diabetes. Sleeping less than 6 hours a night can increase the risk of heart issues.
Regarding social jetlag (SJL), evidence is mixed. Some studies suggest it might lower good cholesterol and raise triglyceride levels, which are fats in the blood. However, other studies indicate it might associate with healthier habits and a lower risk of being overweight.
Overall, both lack of sleep and social jetlag pose some risks to heart and metabolic health. Considering these factors is important when thinking about joining a clinical trial.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how varying sleep patterns might improve cardiometabolic health in ways that traditional approaches haven't addressed. Unlike standard treatments that emphasize consistent sleep duration and timing, this trial examines the effects of intermittent short sleep (ISS) and social jetlag (SJL) on health. The ISS approach introduces variability by alternating between nights of restricted and extended sleep, while the SJL element explores the impact of shifting sleep schedules. These methods could reveal new insights into how sleep variability affects heart and metabolic health, potentially leading to more flexible and personalized sleep recommendations.
What evidence suggests that this trial's sleep patterns could be effective for cardiometabolic health?
Research has shown that getting too little sleep, like the short sleep patterns studied in the Intermittent Short Sleep (ISS) arms of this trial, links to health problems such as obesity and high blood pressure. Both insufficient and excessive sleep can harm heart and metabolic health.
The ISS_SJL arm also tests social jetlag, which is the mismatch between a person's sleep schedule and their body's natural rhythm. Evidence suggests it may increase the risk of diabetes and other metabolic issues, though this link is weaker than the one with short sleep. These findings explain why the study examines different sleep patterns, including the Stable Adequate Sleep (SAS) arm, to understand their effects on heart and metabolic health.23678Who Is on the Research Team?
Marie-Pierre St-Onge, PhD
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for adults aged 18-49 with a BMI of 20-29.9 who usually sleep 7-9 hours without aids or naps. It's not for those who've recently changed weight, are in weight loss programs, have had bariatric surgery, smoke, have sleep disorders, take certain blood medications, have psychiatric conditions including eating disorders and seasonal affective disorder, are pregnant or breastfeeding, have high blood pressure on beta-blockers or diabetes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants undergo a 3-group, parallel-arm, outpatient intervention to test the impact of sleep patterns on cardiometabolic health
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Intermittent Short Sleep (ISS)
- Social Jetlag (SJL)
- Sustained Adequate Sleep (SAS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborator
University of Colorado, Denver
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator